Patents by Inventor David Ballance

David Ballance has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070299006
    Abstract: The invention describes albumin fusion proteins comprising growth hormone and serum albumin. The invention also describes nucleic acid molecules encoding the albumin fusion proteins of the invention, as well as vectors containing these nucleic acid molecules, host cells transformed with these vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally, the invention describes compositions comprising the albumin fusion proteins, and methods of treating patients in need of growth hormone, comprising administering the albumin fusion proteins of the invention.
    Type: Application
    Filed: December 23, 2005
    Publication date: December 27, 2007
    Inventor: David Ballance
  • Publication number: 20070259815
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: April 9, 2007
    Publication date: November 8, 2007
    Applicants: Human Genome Sciences, Inc., Delta Biotechnology Limited
    Inventors: Craig Rosen, William Haseltine, David Ballance, Andrew Turner, Steven Ruben
  • Publication number: 20070060512
    Abstract: The present invention provides modified therapeutic polypeptides or peptides partially or completely protected from DPP activity. The modified polypeptides or peptides comprise at least one additional amino acid at the amino terminus. The modified therapeutic polypeptides or peptides are useful in the treatment of diseases such as diabetes.
    Type: Application
    Filed: March 4, 2004
    Publication date: March 15, 2007
    Inventors: Homayoun Sadeghi, Christopher Prior, David Ballance
  • Publication number: 20060205037
    Abstract: Modified fusion proteins of a transferrini moiety, a GLP-1 moiety and a linker moiety, with increased productivity, bioactivity and serum half-life are disclosed. Preferred fusion proteins include those modified so that the transferrin moiety exhibits no or reduced glycosylation. The fusion proteins of the invention are useful for the treatment of Type 2 diabetes, Type 1 diabetes, obesity, congestive heart failure, and non-fatty liver disease.
    Type: Application
    Filed: March 6, 2006
    Publication date: September 14, 2006
    Inventors: Homayoun Sadeghi, Andrew Turner, Christopher Prior, David Ballance
  • Publication number: 20060194735
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disordrs or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: May 8, 2006
    Publication date: August 31, 2006
    Applicants: Human Genome Sciences, Inc., Delta Biotechnology Limited
    Inventors: Craig Rosen, William Haseltine, David Ballance, Andrew Turner, Steven Ruben
  • Publication number: 20050266533
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disordrs or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: March 14, 2005
    Publication date: December 1, 2005
    Inventors: David Ballance, Darrell Sleep, Christopher Prior, Homayoun Sadeghi, Andrew Turner
  • Publication number: 20050186664
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disordrs or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: February 11, 2004
    Publication date: August 25, 2005
    Inventors: Craig Rosen, William Haseltine, David Ballance, Andrew Turner